Vertex Pharmaceutic Profitability Analysis

VRTX
 Stock
  

USD 305.72  0.19  0.06%   

For Vertex Pharmaceutic profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Vertex Pharmaceutic to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Vertex Pharmaceutic utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Vertex Pharmaceutic's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Vertex Pharmaceutic over time as well as its relative position and ranking within its peers. Also, please take a look at World Market Map.
  
Vertex Pharmaceutic Price to Sales Ratio is fairly stable at the moment as compared to the past year. Vertex Pharmaceutic reported Price to Sales Ratio of 9.53 in 2021. Sales per Share is likely to rise to 31.71 in 2022, whereas Return on Sales is likely to drop (0.007768)  in 2022. Vertex Pharmaceutic Accumulated Other Comprehensive Income is fairly stable at the moment as compared to the past year. Vertex Pharmaceutic reported Accumulated Other Comprehensive Income of 19.06 Million in 2021. Net Income is likely to rise to about 2.5 B in 2022, whereas Consolidated Income is likely to drop (104.3 M) in 2022.

Vertex Pharmaceutic Revenues

8.17 Billion

Is Vertex Pharmaceutic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vertex Pharmaceutic. If investors know Vertex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vertex Pharmaceutic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
11.1
Market Capitalization
75.5 B
Quarterly Revenue Growth YOY
0.23
Return On Assets
0.14
Return On Equity
0.3
The market value of Vertex Pharmaceutic is measured differently than its book value, which is the value of Vertex that is recorded on the company's balance sheet. Investors also form their own opinion of Vertex Pharmaceutic's value that differs from its market value or its book value, called intrinsic value, which is Vertex Pharmaceutic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vertex Pharmaceutic's market value can be influenced by many factors that don't directly affect Vertex Pharmaceutic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vertex Pharmaceutic's value and its price as these two are different measures arrived at by different means. Investors typically determine Vertex Pharmaceutic value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vertex Pharmaceutic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Vertex Pharmaceutic Shares Owned by Institutions vs. Shares Owned by Insiders Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Vertex Pharmaceutic's current stock value. Our valuation model uses many indicators to compare Vertex Pharmaceutic value to that of its competitors to determine the firm's financial worth.
Vertex Pharmaceutic is rated first in shares owned by insiders category among related companies. It is rated first in shares owned by institutions category among related companies producing about  376.56  of Shares Owned by Institutions per Shares Owned by Insiders. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Vertex Pharmaceutic by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Vertex Pharmaceutic's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Vertex Pharmaceutic's earnings, one of the primary drivers of an investment's value.

Vertex Shares Owned by Institutions vs. Shares Owned by Insiders

Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Vertex Pharmaceutic 
Insiders Shares 
 = 
Executives Shares 
Employees 
0.25 %
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Vertex Pharmaceutic 
Shares Held by Institutions 
 = 
Funds and Banks 
Firms 
94.14 %
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.

Vertex Shares Owned by Institutions Comparison

Vertex Pharmaceutic is currently under evaluation in shares owned by institutions category among related companies.

Vertex Pharmaceutic Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Vertex Pharmaceutic, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Vertex Pharmaceutic will eventually generate negative long term returns. The profitability progress is the general direction of Vertex Pharmaceutic's change in net profit over the period of time. It can combine multiple indicators of Vertex Pharmaceutic, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for 2022
Accumulated Other Comprehensive Income19.1 M20.6 M
Consolidated Income-96.6 M-104.3 M
Net Income2.3 B2.5 B
Net Income Common Stock-128.9 M-139 M
Net Loss Income from Discontinued Operations-62.7 M-67.6 M
Net Income to Non Controlling Interests25.2 M27.2 M
Operating Income2.8 BB
Income Tax Expense15 M16.2 M
Net Income Per Employee600.5 K647.9 K
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts. Vertex Pharmaceutic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 00 people.

Vertex Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Vertex Pharmaceutic. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Vertex Pharmaceutic position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Vertex Pharmaceutic's important profitability drivers and their relationship over time.

Vertex Pharmaceutic Profitability Trends

Vertex Pharmaceutic profitability trend refers to the progression of profit or loss within a business. An upward trend means that Vertex Pharmaceutic's profit has generally increased over time, and a downward profitability trend means profits are declining. Recognizing problems early in profitability trends allows investors to address revenue and cost issues in advance. Investors and analysts usually monitor three types of profitability trends: gross, operating, and net. Gross profit is the difference between revenue and costs of goods sold. Operating profit is Vertex Pharmaceutic's gross profit minus its overhead. After you account for other unusual revenue, expenses, and costs, you get net profit. Gross profit trends are often a good indicator of future profitability. If you have high gross profit margins, you have a better chance to cover overhead and make money.

Vertex Pharmaceutic Profitability Drivers Correlations

One of the toughest challenges investors face today is learning how to quickly synthesize and read into endless financial statements and information provided by the company, SEC reporting, and various external parties. Understanding the correlation between Vertex Pharmaceutic different financial indicators related to revenue and profit generation helps investors identify and prioritize their investing strategies towards Vertex Pharmaceutic in a much-optimized way. Analyzing correlations between profit drivers that are directly associated with dollar figures is the most effective way to break down Vertex Pharmaceutic's future profitability.

Use Vertex Pharmaceutic in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vertex Pharmaceutic position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vertex Pharmaceutic will appreciate offsetting losses from the drop in the long position's value.

Vertex Pharmaceutic Pair Trading

Vertex Pharmaceutic Pair Trading Analysis

The ability to find closely correlated positions to Vertex Pharmaceutic could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vertex Pharmaceutic when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vertex Pharmaceutic - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vertex Pharmaceutic to buy it.
The correlation of Vertex Pharmaceutic is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vertex Pharmaceutic moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vertex Pharmaceutic moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vertex Pharmaceutic can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Vertex Pharmaceutic position

In addition to having Vertex Pharmaceutic in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Small Growth Thematic Idea Now

Small Growth
Small Growth Theme
Funds or Etfs that invest in stocks of small to mid-sized companies with above-average risk and growth rate that usually reinvest their earnings back into business. The Small Growth theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Growth Theme or any other thematic opportunities.
View All  Next Launch
Also, please take a look at World Market Map. Note that the Vertex Pharmaceutic information on this page should be used as a complementary analysis to other Vertex Pharmaceutic's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Complementary Tools for Vertex Stock analysis

When running Vertex Pharmaceutic price analysis, check to measure Vertex Pharmaceutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceutic is operating at the current time. Most of Vertex Pharmaceutic's value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceutic's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Vertex Pharmaceutic's price. Additionally, you may evaluate how the addition of Vertex Pharmaceutic to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
To fully project Vertex Pharmaceutic's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Vertex Pharmaceutic at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Vertex Pharmaceutic's income statement, its balance sheet, and the statement of cash flows.
Potential Vertex Pharmaceutic investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Vertex Pharmaceutic investors may work on each financial statement separately, they are all related. The changes in Vertex Pharmaceutic's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Vertex Pharmaceutic's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.